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Foreword 
In more than is written on the following pages, 
this thesis has given me the opportunity to learn of 
scientific research, I now have a greater respect for 
it as a field and as a way of life, a better under¬ 
standing of the complexities involved, and I have gaine 
a better insight into my own future in medicine. 
I have learned that advances in knowledge do not 
(or at least very rarely) take place in giant steps. 
Experiments frequently go wrong for factors unforeseen 
and factors beyond control. Yet in analyzing why this 
happens, learning occurs, and new vistas are opened. 
Technique is important, though often difficult to 
master; the best of intentions and theories alone 
are not enough. 
Progress will come, but the price in thought, 
effort, time and even money is high. There is no 
alternative; we are committed to progress. 
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Introduction 
The problems of viral oncogenesis, immunity, 
and modern chemotherapeutic drugs as anti-viral, 
anti-neoplasic and anti-immune agents are among 
the fastest developing and most fascinating areas 
of medicine. This thesis investigates some aspects 
of these problems 
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Folyoma Virus 
Interest in viral oncogenesis has grown rapidly 
during the past decade. A modern era began in 1951 
when Gross showed acellular derivatives of leukemic AK 
mice could frequently cause newborn C3H Bittner mice to 
(41) 
develop leukemia,v ' Further work by Gross and Stewart 
showed these extracts occasionally caused parotid tumors 
when injected into newborn mice.(^2,43,107,108) 
Stewart, Eddy and others then demonstrated a virus 
in these leukemic tissues which could be grown in tissue 
cultures. Culture lysates inoculated into newborn Swiss 
(HP 
mice did not cause leukemia, but various solid tumors. ’ 
111 115) 
’ It was further shown, by recovering this virus 
from tissue culture plaques caused by individual parti¬ 
cles, that it induced the wide range of solid tumors 
but not leukemia. It therefore was a "passenger" virus 
distinct from the originally noted leukemia agent.1'''’ 
112,111) 
Using this newly isolated virus the above investi¬ 
gators could induce various tumors on injection into 
newborn hamsters and rats as well as mice. They sug¬ 
gested the name "Polyoma"1 due to its range both of 
tumors and hosts, 
Polyoma tumors have since been produced in rabbits 
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guinea pigs and mastomys— often, however, only sub¬ 
cutaneous sarcomas are induced with a low efficiency 
and these spontaneously regress with time.(' 
These modern developments were foreshadowed by 
the work of Rous with the fowl sarcoma virus over 
fifty years ago and the observations of Rivers in 
1928. 
Ham and Siminovitch, in an excellent review on 
( 54') 
polyoma induced oncogenesis, have commented' 
From these concepts, expressed through the 
years, it is clear that until relatively recently 
the proliferation observed in such virus tumors 
as were then available was regarded as being 
in the nature of a reaction on the part of the 
cell to a virus whose injurious effect was not 
sufficient to destroy the cell, but was sufficient 
to stimulate its continuous proliferation. In 
other words, virus-induced neoplasia was regarded 
as being in the nature of a continuing response 
of cells to the presence of a persisting injurious 
agent. 
Such a mechanism seemed to have little appli 
cation to neoplasia in man. Pathologists had long 
appreciated that, in general, neoplastic growth was 
due to a change in the nature of the cell or cells 
that became neoplastic and, furthermore, that the 
change involved an alteration in the hereditary 
. 
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constitution of the neoplastic cells because 
their altered characteristics were handed down 
to all their cellular descendants. Cancer in man 
was so obviously related to a genetic change 
in somatic cells and the neoplastic process seemed 
so different from the process by which growth 
of the few virus tumors in animals was explained, 
that it was customary for viruses to receive 
only scant attention in consideration of the 
etiology of tumors in man. 
Polyoma Virus.Strains 
Many strains of polyoma virus, besides the original 
of Stewart and Eddy (SE), have been isolated. 
Carrier state tissue culture (a culture with much 
virus but little cell death, thought due to resistant cell 
mutation and interferon) selects for a polyoma variant, 
(39 26) 
the small plaque type. ^ ' This mutant is more efficient 
that the original wild type in reinfecting such carrier 
cultures. 
Some of the small plaque strains appear to be less 
oncogenic than the large plaque (wild type) strains.''- * 
95,75) 
"M" and "S" strains (developed in bovine milk and 
human serum media, respectively) induce a similar degree 
. 
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of immunity in mice against transplanted polyoma tumor, 
C56 89 56) but vary in oncogenicity. ’ ’ y This has been found 
to only correlate with the interferon production of the 
cells.(35) 
In hamsters, different strains usually cause similar 
degrees of immunity to polyoma tumor transplant, however, 
strains are known which fail to induce this immunity and 
('55') 
even enhance tumor growth. 
Strains may differ in the types of tumor produced. 
One such, the ISS (Instituto Superiore di Sanita Roma), 
when inoculated into newborn hamsters causes over eighty 
per cent of these animals to develop hepatic lesions 
identified as cavernous angiomata. These lesions cause 
T9) death from peritoneal hemorrhage. ' 
In the experiments described in this thesis the 
"Toronto" polyoma strain was used. This was obtained 
through the courtesy of Drs. Arthur W. Ham and Louis 
Siminovitch. It was originally derived from a spontaneous 
(54 no,\ 
mammary tumor in a C3H mouse, w 
A cytopathic effect from extracts of this tumor was 
demonstrated in cultures of mouse embryo and mouse kidney 
(54 79') 
cells.w ’ ' This strain is serologically the same as 
the SE and also agglutinates rabbit and guinea pig 
(79') 
erythrocytes. v' '' 
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The Toronto strain is more oncogenic in hamsters and 
(JQ) 
rats than is the SE. It rapidly induces kidney sarcomas 
in new born hamsters— six days after inoculation a pro¬ 
liferative response predominates over the necrotic reaction 
and thousands of centers of tumor formation may be found 
in the kidneys. ' When more dilute virus is injected 
into newborn hamsters, a variety of tumors develop after 
(79 j 
a longer latent period. ' 
Other Viruses Tumorigenic in Hamsters 
Other viruses, such as simian vacuolating (SV40), 
can also cause tumors in hamsters. This particular virus 
is similar in size and structure to polyoma. It can, like 
polyoma, immunize animals against its viral induced tumor 
cells; these animals show no cross resistance to polyoma 
(18^ 
tumor cells. 3 Other viruses oncogenic to hamsters in¬ 
clude several adenovirus types and a strain of Rous fowl 
(67, 70) 
sarcoma virus. '’ ' J 
Polyoma Virus Quantitation and Hemagglutination 
An important development in handling polyoma virus 
and making it a laboratory tool is an assay based on the 
virus' agglutination of mammalian erythrocytes. It can thus 
be quantitated without the time-consuming method of tissue 
. 
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culture plaquing and can be specifically identified by 
(51) 
antisera in a hemagglutination inhibition test, ^ ' 
When polyoma is grown in tissue culture it can be 
harvested by simply collecting the culture media. The 
hemagglutinating activity of this media can be concentrated 
by precipitation with ammonium sulfate or ethanol. Further 
purification and appropriate testing show the hemagglut¬ 
ination and cytopathogenicity develop together and are 
directly related. This indicates that hemagglutination is 
a meaningful method of measuring the virus. Heat, however, 
inactivates the virus while the hemagglutinating properties 
• (15) remain,v ^' 
Virus infectivity can also be quantitated by hemagglut¬ 
ination endpoint titration, and by plaquing on mouse or 
hamster tissue culture, 
Polyoma Virus Production 
Polyoma virus is readily grown in tissue culture, 
usually on mouse embryo cells,Another method for 
producing large amounts is in mouse ascites tumor cells 
(86) in vivo. 
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Superinfection of Pol.yoma Tumor Cells 
Polyoma induced mouse tumors, when explanted into 
tissue culture, somewhat surprisingly show cytopathogenic 
effects when fresn virus is added. ^2,51,61,58,59) gi^ere 
V 
is, however, a wide variation (a thousand times) in the 
sensitivity of these polyoma induced tumor cell lines to 
fresh polyoma virus, and these lines are at least ten times 
more resistant to polyoma than normal mouse cells. 
Some non-polyoma tumors are also resistant to polyoma 
. , (62) 
virus infection.v ' 
Since this superinfection is possible, Eellstrbm, a 
prominent worker in the field, has concluded these polyoma 
tumor cells are not analogous to lysogenic bacteria (bact¬ 
eria, which when infected by virus-like phage particles, 
can continue to function and are resistant to superinfec- 
tion).(62,106) 
Polyoma Virus Replication 
Polyoma, like Shope papilloma, SV40 and human wart 
virus, is an intranuclear oncogenic virus. 
When appropriate cells are exposed to polyoma an un¬ 
stable adsorption complex, dependent on such physical 
(11) factors as temperature and pH, occurs. J Though it is 
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well known that interferon acts intracellularly, viral 
adsorption (especially in explanted polyoma tumor sub- 
jected to superinfection) correlates with interferon 
production. 
Then, somehow, the virus or part of it enters the 
cell nucleus. Fluorescent antiviral staining is exclu¬ 
sively localized here in early infection; later the virus 
may be found in both nucleus and cytoplasm.After a 
relatively long latent period of about twenty hours, cell 
death starts, The dual necrotizing and proliferative 
response characteristic of polyoma infected cells then 
. (54,26) 
may be seen,w ’ ' 
In infected mice nuclear replication is detected by 
the immunofluorescent technique is such tissues as con¬ 
nective, skin, mesenchymal, and tubular kidney, peri¬ 
osteum, bone marrow, thyroid and thymus— in fact in 
all tissues in which polyoma tumors have been observed. 
After tumor formation this virus can rarely be localized.^01' 
Electron microscopy confirms this-- viral particles 
are seen in greatest number in tbe nuclei of kidney cells 
of newborn hamsters five to six days after inoculation, 
(65 66 54) 
and at the peak of the necrotizing response. ^ 
-8- 
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Folyoma Virus DNA 
Polyoma has been widely confirmed to be a deoxyribo¬ 
nucleic acid (DNA) virus. This DNA is known to be 
the infective part; empty viral protein shells alone are 
ineffective. 
The fundamental properties of DNA and RNA (ribonu¬ 
cleic acid) viruses would seem to be largely different, 
though both may cause the malignant transformation of nor 
mal cells. Since in normal cells DNA is known to be the 
site of gene action and RNA of protein synthesis, these 
two types of viral oncongenic agents would appear to at 
least initiate their effects differently. 
Purified polyoma DNA denatures atypically and sedi¬ 
ments as two components. This is due to a linear and a 
(119 27 *>0') 
ring form. ’ ’ ' Either form can infect, cause lytic 
(12) plaques and transform cells in tissue culture. ' 
Polyoma DNA has about five thousand nucleotide pairs 
considered sufficient to specify approximately fifteen 
hundred amino acids or ten small proteins„ ’^) Its 
functions seem to be the synthesis of protein units of 
the viral shell, formation of the new surface antigen of 
the transformed cells, and possibly, an ability to in¬ 
crease cellular enzymes for DNA synthesis. 
_ 
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Autoradiography and immunofluorescent studies have 
indicated that when cells are infected DNA synthesis is 
increased0 This increase has been shown to be largely 
(29') 
cellular DNA. Later, viral protein formation occurs 
in the characteristically prominent nucleolus0ip^e 
host cell rate of DNA synthesis at the time of infection 
is not significant in its susceptibility to infection."®-^ 
X-irradiation of cells, which eliminates cellular 
DNA formation does not affect the cells’ ability to sup¬ 
port viral multiplication* (In these experiments virus 
is added after irradiation since polyoma is radiation 
(o') 
sensitive.)v J 
The process of polyoma virus multiplication is slow 
and asynchronous, 
Conflicting work exists concerning the recoverability 
of polyoma DNA from transformed cells. Early investigations 
showed a significant number of polyoma tumors to be free 
of virus, although such tumor cultures were subjected to 
x-ray, ultraviolet irradiation, cortisone, nutritional 
deficiency, superinfection with other viruses, and growth 
on a polyoma sensitive feeder cell layer in an effort to 
elicit a latent virus. ^ J These seemingly virus- 
free tumors still retained specific polyoma-induced trans¬ 
plantation and complement-fixing antigen. 
Other studies indicate that tumorigenic DNA can be 
- - 
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extracted from mouse cells infected in culture 
in vivo tumors, though some contain very little 
arid certain 
( 25 
virus. 
51,2,87,57) 
Malignant Transformation of Cells by Polyoma 
Polyoma virus can transform a tissue culture of 
normal hamster cells to malignant cells. About a 
million virus particles must be used for one transforming 
event— and regardless of the virus concentration ten to 
twenty per cent is the upper limit of cells transformed— 
it is not clear if this is due to few active virus parti¬ 
cles or other factors.in cloned, genetically identi¬ 
cal cells, exposed to polyoma, there is evidence that the 
cells' physiologic state may be important in its response. 
The criteria for transformation are generally con¬ 
sidered to be: increase growth potential; loss of the nor¬ 
mal contact inhibition between neighboring cells which 
prevents multilayers in normal cultures; chromosomal aber¬ 
ration; a new specific viral-tumor antigen; a change in 
the cell's response to regulatory influences; possibly 
a change in its enzyme activity and in the composition 
of its surface; and most important, its ability to cause 
26 49 ) 
a tumor when injected into an appropriate host. * ’ y 
-II- 
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Hamster embryo cultures transformed by polyoma fre¬ 
quently have a thick new coat of mucopolysaccharides-- 
it has been suggested this increase in sialomucin at the 
cell surface is a major factor in the loss of contact in- 
(22) hibition and change in morphology. ' Loss of contact 
inhibition generally correlates well with the tumorigen- 
icity of the transformed culture on animal inoculation. ^ ^ 
The previously mentioned criteria for transformation, 
however, do not always correlate with malignancy. Indeed, 
some cell lines which have been transformed by morphologi¬ 
cal criteria are of relatively low malignancy, and it is 
questionable whether the hereditable differences in the 
properties of the transformed cells are not the result 
of some secondary factors not essential for malignancy. 
105) 
A tumor cell line (not polyoma induced) which had 
contact inhbition and a "normal" cellular orientation 
lost these characteristics when exposed to polyoma 
(24) 
without any change in oncogenicity. ' 
Murine tissue culture frequently enters a completely 
lytic cycle on exposure to polyoma. 
The New Antigen of Polyoma Transformed Cells 
After in vivo or in vitro infection with polyoma 
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cells have a new specific antigen thought to be as¬ 
sociated with the cell surface, even in apparently virus- 
(l,c cn 4.0} 
free tumors. ' This new antigen may be demon¬ 
strated by complement fixation using transformed cells 
as antigen emd sera from animals carrying transplanted 
polyoma induced tumors or antisera to polyoma virus 
( 57) 
itself after adsorption on normal cells. ' 
Habel, who has done much work in this field, states 
this particular antigen cannot be found in normal tissue 
nor in tumors induced by other viral or non-viral agents. 
Tissue cultures after exposure to polyoma are positive 
for this antigen; unexposed cultures are negative. The 
presence of this antigen in the culture does not depend 
on the presence of infectious virus nor on the malignancy 
of the cells in isologous animals. Sera of tumor-bearing 
animals which have high titers of complement fixing anti¬ 
body against this tumor antigen may be negative for anti¬ 
viral antibodies, and sera from virus-immunized animals 
may be negative against the tumor antigen but have high 
antiviral titers. This is especially true if non-viable 
virus is used for the immunization. The presence of this 
complement fixing antibody against tumor antigen is not 
necessary, however, for virus-immunized animals to resist 
challenge with isologous polyoma tumor. 
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An important implication of this new specific cellular 
antigen is that it seems to indicate an integrated viral 
genome or portion of it in the seemingly virus-free 
tumors/117-57) 
This polyoma tumor antigen is very stable— repeated 
passage of tumors in vivo does not eliminate it.^~C^^ 
Adult mice and hamsters are made resistant to isolo¬ 
gous polyoma tumor by an inapparent infection with the virus. 
This resistance is of the cell mediated (delayed or tuber¬ 
culin hypersensitivity) type and apparently not related 
to antiviral serum antibodies. It is thought to be due to a 
transplantation type of cellular immunity directed against 
(1+1+ 102) 
the "foreign" antigen contained on the tumor cell. ’ J 
Habel theorizes that this phenomenon may explain the lack 
of tumor formation in adult mice who are immunologically 
competent to reject such a foreign antigen, the rarity 
of polyoma tumors in nature, and the oncogenic potential 
(1+1+') 
of polyoma in the immunologically tolerant newborn. J 
In other systems it is known that the development 
of such tumor antigens may accompany the loss of normal 
tissue antigens. 
Historically, such antigens have been long noted in 
cancerous tissue . ’ 122 ^ 
Unique tumor antigens have been reported with chem- 
- 
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ical, and such viral induced neoplasms as adenovirus 12 
and SV 4o.(57’88’68’50’18’71’64) 
The polyoma induced cellular antigen may be passed 
(21) between cell lines by somatic hybridization, ' 
It is now generally accepted that these new specific 
antigens are characteristic of the transforming agent ra¬ 
ther than of the type of cell transformed, ^117’'j8/) 
Polyoma Virus Induced Tumors 
Though widespread in nature, polyoma is rarely 
(94) 
tumorigenic, ' Mice are very resistant to tumor induc¬ 
tion when fifteen days old; large doses can still cause 
tumors in hamsters at twenty-five days,^48^ Adult animals, 
resistant to tumor induction, are nevertheless highly 
susceptible to polyoma infection— very small inocula re¬ 
sult in virus multiplication in various organs followed 
by a serum antiviral response. 
Polyoma virus, especially the Toronto strain, causes 
rapid tumor formation in the neonatal hamster. This has 
been the strain of choice in many research projects, A 
considerable drawback, however, is that when virus is 
titrated in newborm hamsters the tumor development end¬ 
point is quite shaded. 
Kidney tumors are especially frequent in these young 
il ox; s bnB f Lboi 
; r f ( r 
. 
' 
. cad II90 10 eq^d srfd lo ajaifd aerfd 
[ f9UJd£n ax bjB9aqE9biw A iso A^ 
. 
L } bio bv^jf £> a99dlil nsriw noid 
f . 
: 1 o. ni loan/d od dn^isiss'i 
. 
.a 
.' .•eijFfiB 
-16- 
animals, perhaps because hamster kidneys are incompletely 
developed at birth. Nephrons and blood vessels of the 
arcuate system continue to form for several days. The 
many mesenchymal cells which are to form the smooth muscle 
walls of the blood vessels and the kidney stroma are 
(4) 
especially prone to the effects of polyoma.v ' 
Light microscope changes are apparent in these kid¬ 
neys three to four days after virus inoculation— the 
mesenchymal cell foci increase in size; there is much 
mitosis and necrosis. By the eighth day after inoculation 
the necrotic debris is largely removed and the prolifer¬ 
ative effect is predominant. Several days later large 
sarcomas appear. (H7>96.,46) simuitaneous necrotizing 
and proliferative response has also been found in vitro 
Bioassays of these kidneys during the first twenty- 
four hours after inoculation show small amounts of virus, 7 
With the electron microscope the first viral particles 
may be seen at forty hours, and virus production is associated 
with cellular necrosis and few virus particles are seen 
(nq 46") 
with the proliferating cells. ' ' ' After the first day 
the amount of virus present steadily increases until on 
the fourth through the seventh day, at the height of the 
necrotizing response, a virus concentration a million 
times greater than on the first day is found.(93,79) By 
the tenth day, when proliferation is seen, no virus can 
(79) 
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be detected. ^^>'1 
Death in these baby hamsters shows a major peak 
at twelve days from kidney tumors. Another peak at nine¬ 
teen days is from nodular renal and heart tumors; later 
deaths occur from hemorrhage into the pleural and peri¬ 
toneal cavities from vascular dilatations of the liver, 
lungs, intestines and reproductive organs.w J' 
The kidneys of newborns dying early are generally 
greatly enlarged bilaterally. Yet though these organs are 
ten times normal size, their characteristic shape is re¬ 
tained. Cortex and medulla are largely replaced with in- 
( ft 79) filtrative tumor, microscopically made of spindle cells. y'' '' 
The hearts of animals dying sixteen days or less after 
virus inoculation appear grossly normal but have diffuse 
microscopic lesions of myocardial interstitial tissue and 
muscle necrosis. In animals dying later than this, dis¬ 
crete tumor nodules of spindle cell sarcomas grow from 
the heart. 
These tumors can usually be successfully trans¬ 
planted to random-bred adult hamsters; in mice, trans¬ 
plantation is generally only possible in animals of the 
4- • (5,46) 
same strain.w ’ ' 
Virus concentration is an important factor. If new¬ 
born hamsters are given a high concentration, the quick- 
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killing diffuse kidney tumors evolve; with a lower con¬ 
centration the nodular kidney and heart tumors; with a 
still lower concentration, especially, if given sub¬ 
cutaneously, subcutaneous tumors develop along the in- 
(4) 
ejection needle tract. ' 
If routes other than the intraperitoneal and sub¬ 
cutaneous are used, such as the nasal, a predictably 
different tumor range occurs. 
The age of the hamsters influences the incidence of 
tumors. With injections of the same dose of the Toronto 
strain at one day of age all develop tumors, at four days 
still one hundred per cent, and at fourteen days only thirty 
per cent— greater doses are needed for tumor develop- 
(17) 
ment after a longer latent period in older hamsters, ' 
Occasionally, especially after large doses of virus to 
adult hamsters, the animals die several months later of 
hemorrhage from the liver, lungs or kidneys from a lesion 
that is not a gross tumor.^>53) proiiferation of endo¬ 
thelial cells has been reported in these lesions, which 
(23) 
on transplant appear to be hemangiosarcomas. ' 
Theorizations have been advanced as to the unique 
susceptibility of the newborn hamsters: 1) the newborn 
animal is intrinsically more susceptible, 2) lack of im¬ 
munity is due to lack of antibody production— but trans- 
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plants of infected kidneys from two day old hamsters in¬ 
oculated with virus a day previously develop into locally 
invasive tumors in adults (There is some doubt whether 
adults are stimulated to produce antibody with this type 
experiment), 3) infected virus may be distributed dif¬ 
ferently in adult and newborn animals, 4) since pre-im¬ 
munization of adults with polyoma virus decreases the 
progressive growth of polyoma tumor cells on transplan¬ 
tation, perhaps the immunologically poorly reactive new¬ 
born does not ’'recognize1' the tumor antigen as foreign 
and reject these cells (immune tolerance), or 5) virus 
may produce malignat change more rapidly in embryonal 
type cells. ^’17’20’15^ 
Polyoma induced mouse tumors may be carried by trans 
plantation in isologous animals; some tumors show no sign 
of virus release, others have continued release— in 
general connective tissue tumors do not have free virus, 
and other neoplasms do.^112^ 
Polyoma Virus Antibody 
Polyoma is sufficiently antigenic to readily induce 
in vivo antibody. There is much evidence to indicate, how 
ever, that this antibody is not the major defense against 
tumor induction. jn newborn mice, tumor development 
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takes months and antiviral antibody is present from the 
tenth day.^-^ It appears, especially in newborns, that 
cells are determined to neoplasia soon after viral inocu¬ 
lation, and before even the normal animal can have an 
(53 99) 
antibody response. 
Polyoma virus infected mothers pass antibody to their 
suckling offspring in milk.But this does not confer 
(45) 
resistance to tumor development on viral inoculation. 
Antibody given to newborn mice one hour before virus pro¬ 
tects these animals from tumor development— when given 
one hour or twenty-four hours afterwards and once per day 
(33 H4 no 
for seventeen days, there is no protection. ’ ’ ’ 
5D 
Antibody does not change the response of animals 
with tumor. »^5) 
Injections of non-viable polyoma tumor cells are cap¬ 
able of building resistance to tumor formation in the 
immunologically mature animal without inducing antibodies 
of the hemagglutination type.^^' 
It is reasonable to conclude that tumor formation 
is due to early processes at the cellular level, and the 
antibody response eliminates infectious virus, allowing 
no such further induction. 
* 
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Resistance to Polyoma Tumor 
Exposure to infectious polyoma (such, as being near 
infected animals) results in a specific resistance in ham¬ 
sters and mice to transplantable isologous tumors which 
(117 44 
are polyoma induced but free of infectious virus. ’ ? 
102,46,47,100) j_n mice can develop to such a 
degree that though these animals develop small tumors when 
(45) 
challenged with tumor cells, later these tumors regress. 
(19) In hamsters such resistance is not as well developed. ' 
Hamsters immunized by non-viable polyoma tumor cells 
(45) 
show a slower growth at tumor transplant. Mice given 
repeated non-isologous tumor grafts, more quickly reject 
a polyoma tumor isograft, though these animals are free 
of antiviral antibody, ^ 
Mice which receive spleen, thymus, bone marrow and 
axillary lymph node cells from isologous virus immune ani¬ 
mals develop transplant tumors more slowly than control 
animals. This effect of lymphoid tissue can be distin¬ 
guished from the resistance induced by accidental virus 
infection since these recipient animals have no antibody, 
ij-’here seems to be a lack of resistance after immuni¬ 
zation with inactive virus, which induces serum antibody 
(99) 
but gives no transplantation type resistance (45) 
It therefore appears that resistance to tumor challenge 
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is cell mediated. Indeed, in hamsters, transplantable 
tumors frequently show a heavy infiltration of lympho- 
(19) 
cytes, plasma cells and mast cells. ' 
Effect of X-irradiation 
X-irradiation of mice (about four hundred rads) a 
day before polyoma tumor cell injection reduced resistance 
to transplant; when the radiation is given four days later 
(99) 
there is little effect. ' The irradiated adult seems 
to be comparable to the newborn, requiring one-tenth to 
one-hundredth the tumor cells needed by a normal adult 
(4q 47 100) 
for a successful transplant. > ' After irradiation, 
intravenous administration of virus to adult mice, which 
are ordinarily quite resistant to this challenge, causes 
(74) 
tumors to develop in some. ' ' 
Mice already immunized against polyoma virus and 
then irradiated, show less resistance to tumor challenge 
(45) 
that unirradiated immune animals. ^J This may be due to 
the destruction of radio-sensitive lymphoid tissue the 
tumor cell challenge would ordinarily act on as an anti- 
(45) genic booster. y Mice immunized with polyoma tumors 
from non-isologous murine strains, however, do not appear 
to have resistance to isologous polyoma tumor grafts 
(100) lessened by radiation. 
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Eight to fifteen thousand rads given to tumor cells 
prior to transplantation abolishes their ability to in¬ 
duce resistance. ^This dose is known not to harm 
the virus which may be present. This lack of effect may 
be due to the lack of proliferation of these non-viable 
cells after injection. 
Effect of Thymectomy 
A strain of mice (C57B1) known to be highly resistant 
to polyoma, even when inoculated on the day of birth, were 
thymectomized at three days of age. These animals did not 
show the stunting of growth or features of wasting char¬ 
acteristic of mice thymectomized within twenty-four hours 
after birth, and also had a fair lymphocyte count (com¬ 
parable to that of thymectomized adults though less than 
that of sham operated controls). These thymectomized ani¬ 
mals could develop hemagglutination inhibition antibody 
to virus though usually at a slightly lower level than 
controls. These thymectomized mice developed many more 
tumors after virus inoculation even tnough the viral 
growth in the kidneys, salivary glands and liver were 
similar to that of the controls» ' ^ 
Restoration of immunological competence by transplant 
of lymphoid tissue to thymectomized neonates is effective 
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in returning the resistance to polyoma virus tumor induc¬ 
tion. This again indicates that resistance to tumor 
development is a cellular immunity of the homograft type. 
Immune Tolerance to Polyoma 
Non-viable tumor cells injected into newborn mice 
make these animals more susceptible to tumor challenge 
(45 47 ) 
as adults. y* ' This suggests the development of immune 
tolerance to the tumor antigen. 
Virus challenge of adult mice made tolerant with non- 
viable tumor cells as newborns, however, does not cause 
(45 j 
tumors. ' The animals may at this stage be able to handle 
the virus challenge with serum immunity mechanisms. 
Effect of Genetics on Polyoma Susceptibility 
Certain strains of mice are highly resistant to poly- 
(15) 
oma virus tumor induction. Various tissues from these 
resistant mice, show no in vitro special resistance to 
(69 72) 
polyoma infection. ’ ' 
There is evidence that this resistance may rest with 
certain Mendelian segregating genes. 
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Bacterial Lysogeny 
The action of polyoma virus on living cells has been 
compared at times to bacterial lysogeny. In this phenomenon 
a DNA bacterial virus known as a phage gains entrance into 
a bacterium and can either multiply and kill this cell 
or can become integrated (now known as a genome) with the 
bacterium. The integrated viral genome is known as a pro¬ 
phage and the process is known as lysogeny. This prophage 
multiplies synchronously with the host bacterium and renders 
the bacterium immune to superinfection with a similar phage. 
Under certain conditions an occasional bacterium will 
lyse with new phage being produced. 
Since superinfection of polyoma tumor cells with fresh 
polyoma virus occurs, this analogy is not complete. 
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Relevant Antimetabolic Prugs 
Halogenated Pyrimidines 
As part of a rational search, based on fundamental 
biochemistry, for antimetabolic agents for possible use 
in neoplasm therapy, 5-iodo-2'-deoxyuridine (IUdR) was 
sought. The synthesis of the halogenated pyrimidines 5- 
("48 45 iodouracil and 5-iodocytosine had long been known. ’ ’ 
5-Iodouracil was also known to have limited anti- 
(45) bacterial properties. 
The elusive synthesis of this nucleoside analog of 
thymidine was accomplised by Prusoff in 1958.'^“' 
IUdR mimics thymidine. Its slightly different prop¬ 
erties, due to the substitution of an iodine atom for the 
methyl group at the 5-position of thymidine, accounts for 
its subtle effects. 
As shown in Figure 1, IUdR and its corresponding 
phosphorylated derivatives inhibit the utilization and 
replace thymidine, thymidylic acid and thymidine triphos¬ 
phate in the formation of deoxyribonucleic acid (PNA), 
thus slowing PNA production arid altering the properties 
of the resultant DNA.(23,24,56,14,62,20,72,77) 
This unnatural lUdR-PNA has greater than normal 
molecular interchain attraction, which slows its repro- 
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duction.^ ^ Quite likely, innacurate DMA replication 
also occurs. Perhaps this accounts for the gross chromo¬ 
somal aberrations noted in tissue culture cells exposed 
to IUdR/44' 
IUdR also appears to inhibit both the cellular aspar¬ 
tate -transcarbamylase system of de_ novo pyrimidine synthesis 
(as does thymidine naturally) and the various thymidine 
enzymes such as thymidine kinase, thymidylic acid kinase 
and DM polymerase at a site characteristic of the parti- 
i .. (63,4,64,20) 
cular tissue. ’ * ’ J 
Thymidine is used by cells preferentially over IUdR 
and can competitively inhibit IUdR in its phosphorylation 
(64 51) 
and incorporation into DUA. ’ ' Thymidine can thus 
specifically protect in vitro and in vivo against an 
otherwise lethal dose of IUdR. 
Arnethopterin, a folic acid antagonist, which inhibits 
the formation of thymidylic acid from deoxyuridylic acid, 
(35) increases the incorporation of IUdR into DM. 
IUdR is rapidly broken down by intestinal enzymes, 
precluding oral administration. Its low solubility (about 
5 mg per ml saline) relative to dosage needed makes intra- 
( 78 ) 
muscular1 administration difficult. ' In small animals 
the intraperitoneal and subcutaneous routes are most 
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satisfactory; clinically in man intravenous administration 
may be used. 
The vehicle is important. There is evidence that an 
oil emulsion of the drug gives greater tissue uptake than 
an aqueous solution. The drug is quite soluble in di¬ 
methyl sulfoxide (DMSO), a commercial solvent of relatively 
low toxicity derived from wood pulp. 
The in vivo breakdown of IUdR is rapid. In the mouse 
about three-quarters of the activity of radio-labelled 
( 68 ) IUdR is found in the urine in four hours. ' The likely 
pathways for this catabolism are shown in Figure 2. Met¬ 
abolic dehalogenation of IUdR directly does not appear 
to occur. 
In tissue culture, as would be expected, proliferating 
(S') 
cells are affecied more than resting cells by IUdR. 
Tissue cultures of normal mouse embryo cells, exposed 
to 10 microgms IUdR per ml medium for forty-eight hours, 
show inhibition of cell division which is not reversible 
('57') 
with thymidine. J Characteristically cell multiplication 
halts after one or two divisions at such a concentration 
(only about a third of such an exponentially growing cell 
population is synthesizing UNA at any given time).^^’ 
78) 
The cytotoxicity of IUdR for some representative cell 
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IUd R~—->1 od ourac il 
Iodinated 
degradation 
products 
corresponding 
to uracil 
metabolism 
■^Iodine———^Iodinated non-nucleic 
+ acid derivatives 
Uracil 
anabolic derivatives 
(beta alanine, etc.) 
Figure 2. 
The in vivo catabolism of IUdR (68,55,52) 
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cultures is given in Table 1. 
Animal toxicity studies with IUdR show mice to have 
an acute ID^q of 2.5 gm per kg, to tolerate 100 mg per kg 
for six days without toxicity, and to have a subacute LD 50 
of 318 mg per kg over thirteen daily doses. Dogs given 100 
mg per kg for twenty days have toxic effects of anorexia, 
leukopenia, thrombocytopenia and gastrointestinal bleeding. 
In human clinical studies stomatitis, leukopenia and 
(6) 
alopecia have been noted. 
64) 
IUdR inhibits the growth of some murine neoplasms. 
Its clinical use as an antineoplastic agent has had 
(6,58) 
(47, 
some success. 
IUdR's more unique property, however, is in the inhib¬ 
ition of DBA viruses. It can interfere with tissue culture 
plaque formation by such DUA viruses as vaccinia and herpes 
simplex.^^^ This occurs selectively at a concentra¬ 
tion which stops the virus but does not harm the culture 
cells, thereby having a favorable therapeutic ratio for 
(54') this purpose. w J IUdR is thought not to have a direct 
antiviral effect but to act by its incorporation into 
viral DNA. ^5) Ribonucleic acid (RM) viruses, such as 
polio and Coxsackie, are in general unaffected by IUdR. (54) 
(68, 
A strain of Rous fowl sarcoma virus, however, has been re¬ 
ported to have its multiplication inhibited by the drug.' 
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microgms 
per ml 
He La Rabbit kidney 
Rat 
kidney HEp-2 
IUdR CA IUdR CA IUdR CA IUdR CA 
100 + + + + + + + + 
50 + + + + + + + + 
25 + + - + + + + + 
12.5 + + - + _+ + - + 
5 - + - + - - - 
1 - .+ - + - + - - 
°5 - - - + - - - - 
.2 - - - - - - - 
0 _ _ _ _ _ _ _ _ 
Table 1 (from Buthala)^) 
The cytotoxicity of IUdR and CA in newly planted cultures. 
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IUdR is effective against experimental ini vivo 
(7.0 O') 
herpes simplex and vaccinia skin lesions. 9 Clini¬ 
cally, its use in human herpes simplex keratitis is now 
('49') 
well established. 
IUdR inhibits the oncogenic effect of adenovirus 12 
on newborn hamsters in a dosage non-toxic to the animals. - ' 
Animals which do develop the tumors do not have complement 
(45) fixing antibody suppressed by the drug. 
IUdR can inhibit the in vitro and in vivo oncogenic 
effect of polyoma virus. ^ ^ 
( 55 The pyrimidine analogs are mutagens for bacteriophage.'''’ 
55 ) Although IUdR cannot cause malignant transformation 
itself, it has been reported to increase the transforma- 
(75) tion rate of SV40 virus on actively growing cultures. 
An intriguing aspect of the halogenaced pyrimidine 
analogs is their reduction of the threshold of cells to 
roentgen and ultraviolet radiation damage . ^ ’ "L 7 ’ 
There appears to be a direct correlation netween the de¬ 
gree of replacement of DNA-thymine by IUdR and the in¬ 
creased radiation sensitivity. Such radiation 
sensitization of rapidly proliferating tissue may be of 
(9) 
clinical importance. ' 
- - 
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ICdR 
In order to develop a more efficient form of IUdR, 
which itself is so readily split into iodouracil and 
deoxyribose by nucleosidase action, since there was evi¬ 
dence that 4-aminopyrimidine compounds (cytosine type) 
were more resistant to such catabolism, Welch postulated 
that 5-iodo-2’-deoxycytidine (ICdR) might escape this 
enzymatic degradation and enter the cells unchanged to 
subsequently be phosphorylated and deaminated to form 
IUdR-phosphate intracellularly.^^^ 
Accordingly, this compound was synthesized. (-^>-*-5) 
Initial experimental studies, however, revealed that 
the conversion of ICdR-5'-P to IUdR-5'-P by deoxycytidylate 
deaminase was limited and much of the drug was deaminated 
by a nucleoside deaminase before phosphorylation to form 
IUdR, as shown in Figure 1.(^7>52,18) 
As would be expected, ICdR has the effects of its 
IUdR derivatives. There may be variations in the specific 
derivatives though, dependent on the organism's character- 
(7) istic deamination pattern. 
Of practical importance, ICdR has greater aqueous 
solubility and heat stability than IUdR (the latter must 
(12) 
be sterilized by ultrafiltration).v J 
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AzUR 
Azauridine (6-azauracil riboside, AzUR), prepared by 
Handschumacber in 1957, is an antimetabolic drug which 
as its intracellular derivative 5'-phosphate (azauridylic 
acid) inhibits the enzyme orotidylic acid decarboxylase 
which ordinarily forms uridylic acid from orotidylic acid, 
, . , (57,40,58,41,59) 
as shown m Figure 5* ’ 
On a molar basis AzUR is ten to twenty times more 
active than its parent pyrimidine, azauracil, in inhibiting 
certain murine tumors, it has little toxicity, is rap¬ 
idly excreted unchanged renally, and may be given orally 
to mice or dogs.^^) Pure AzUR lacks the hypnotic properties 
of azauracil. (^,79) 
Triacetylation of the free hydroxyl groups of AzUR 
results in a compound suitable for oral administration 
(59 19) in man, without breakdown to azauracil.' 
AzUR is soluble to about one gm per ml water, may 
be heat sterilized and is distributed in general according 
(59) to the body water. ' 
AzUR has been used with limited success in human 
leukemia and, as triacetyl azauridine, with considerable 
(2 74) 
success m the treatment of generalized psoriasis. y 
Man and other animals studied appear to have no enzyme 
- - 
f (HUs f >bx8odx*i Ixojb'iubsjb-cO snxb..‘iis&sA 
: 
19b 'I&LlI r SOBlti&i 2d x 3B 
uJ i^dnswd od nsd ex HUs/. axs.sd tbJohi 
••• '^53 
, Xxojbtj;..'- 
tol rfld'-drxfs bauoqmor> jb isx fidJt/aen 
-•3d ci^cildiw fnBm fii 
. .“7SW 'bod -r'l cd 
U9 8d 3BI1 ft Us A 
8jb <£ ib rimsjfusl 
, 9 r! d o ocub Afji ! 
-36- 
Orotic 
acid 
Orotic acid 
Nucleic acids 
■^and coenzymes 
Figure 3• 
(40) Inhibition of uridylic acid synthesis by azauridine. 
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capable of cleaving ribose from AzUR. Resistance to the 
drug can occur, however, by lack of formation of the 
5 1 -phosphate (azauridylic acid).^^'1 
CA 
Cytosine arabinoside (1- -D-arabinofuranosylcytosine, 
arabinosyl cytosine, CA) is an antimetabolic agent whose 
primary effect is the inhibition of reduction of the ribose 
(15 69) precursor, cytidylic acid, of deoxycytidylic acid. v' 
Ca is incorporated into DRA and RNA (though the syn¬ 
thesis of the latter is unimpaired 
Deoxycytidine and its derivatives specifically counter¬ 
act CA. In tissue culture it is slightly more toxic than 
the same concentration (wt/vol) as IUdR, as shown on Table 
1. The subacute LD^q (five daily doses) for mice is 
(50') 34-0 mg per kg per dose. J 
CA has antineoplastic activity and antiviral properties 
(26 5) 
against a number of DRA viruses. 
. 
. 
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Experiments 

Experiments on 
the Suppression of Serum Immunity in Mice 
by Antimetabolic Agents 
Partly because serum antiviral antibody has a role 
in polyoma virus oncogenesis, it was thought desirable 
to investigate the effect of various antimetabolic agents 
on the development of serum antibody. 
Mice were used since such techniques have been well 
worked out for this species. They are also conveniently 
available and relatively inexpensive, both for the con¬ 
siderable number of animals needed and the quantity of 
drug necessary for appropriate dosage. 
Materials and methods. 
Mice. The animals used were random-bred specific pathogen- 
free white Swiss CD-I mice (Charles River Breeding Labora¬ 
tories, North Wilmington, Mass.), 7 to 9 weeks of age, 
with an average weight of JO gm. 
Antigen. Sterile sheep blood in Alsever's solution (Probio, 
Inc., Nyack, N.Y.) was used, usually within 7 days of 
collection. Plasma was separated by centrifugation and 
the cells were washed three times with pH 7.2 isotonic 
phosphate buffered saline, and then resuspended in the 
same medium. This preparation was done directly before 
use. 
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Drugs. In the series of experiments the following drugs 
were used: normal (0.9%) saline solution, heat sterilized; 
5-bromo-2'-deoxyuridine (BUdR), obtained from Schwarz Bio- 
Research, Inc., lot #DBU6002, through the Cancer Chemo¬ 
therapy National Service Center; 5-iodo-2'-deoxyuridine 
(lUdR), lot #5272, purchased from Nutritional Biochemicals 
Corp. ; 5-iodo~2'-deoxycytidine (ICdR), prepared by P.K. 
Chang, Department of Pharmacology, Yale University School 
of Medicine; 6-azauridine (AzUR), obtained from the Cancer 
Chemotherapy National Service Center as NSC 32074, lot 
#12-34-004; dimethyl sulfoxide (DMSO), reagent grade; 
azathioprine (Imuran, BW 57-322), lot #45374, obtained 
through the kindness of Dr. G.B. Elion of Burroughs Well¬ 
come and Co.; chloramphenicol succinate, sodium ester, 
obtained through the kindness of Dr. A.C. Bratton, Jr. 
of Parke, Davis and Co.; amethopterin (Methotrexate, MTX), 
lot #J-0906 obtained from Lederle Laboratories Division, 
American Cyanamid Co.; cytosine arabinoside (Cytarabine, 
CA), obtained as U-19920, lot #14, 866-2MZ, through the 
kindness of Dr. C.G. Smith of the Upjohn Co.; and deoxy- 
cytidine (CdR), purchased from Nutritional Biochemicals 
Corp. 
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Serum collection. At the end of each experiment the mice 
were sacrificed by cervical dislocation and blood was 
collected separately for each animal by cutting the great 
vessels just above the heart; after clotting and centri¬ 
fugation the individual sera were used for determination 
of hemagglutinins a 
Hemagglutinin reaction. The hemagglutinin titer was deter- 
(7) 
mined according th the metnod of Stavitsky. ' Serial 2- 
fold dilutions were carried out in 8 x 10 hole Perspex 
plates beginning with a dilution of 1:8 (1:2J) to a dilution 
12 
of 1:4096 (1:2 ). In experiment 1 the initial hole con¬ 
tained .875 ml heat inactivated (56°C one hour) normal 
rabbit serum, and the remaining holes contained 0.5 ml normal 
saline. In experiments 2 and 3 the initial hole contained 
.875 ml of an 0.1% gelatin in saline solution, and the 
remaining holes contained 0.5 ml of this solution. 
In some cases less than .125 ml mouse serum was 
available; appropriate mathematical corrections for these 
dilutions have been made in the calculations. 
To each hole 0.1 ml of a 1% suspension of triply, 
phosphate buffered saline, washed sheep erythrocytes 
were added. The plates were well mixed by a Vortex mixer 
after preparation. 
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The plates were covered and kept at room temperature 
for 24 hours. They were then read on an 0 to 4+ basis, 
(7) 
as described by Stavitsky.v 7 
Antibody index. This was calculated as described by Nathan, 
Bieber, Elion and Hitchings.^^ "The score for each tube 
was multiplied by the appropriate exponent of the 2-fold 
dilution series, i.e„, a tube showing a 4+ agglutination 
at a dilution of 2^ would have a value of 24. These values 
were then summed for each series. The index of the drug 
effect was obtained as the ratio of these sums for the 
treated to untreated controls: 
2T(S,+2SP+3S*+....nS )T 
Antibody Index (A.I.) = ----—’ 
S-.(S1+2S2+3S5 + ... .nSn)C 
where n refers to the exponent of the dilution, S is the 
agglutination score for the tube and T and C refer to 
treated and control series, respectively." 
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Experiment 1 
The data and results of experiment 1 are summarized 
in Table 1. 
Procedure. The drugs were made up as follows: normal saline; 
BUdR 2.25 mg per ml saline; IUdR 5 mg per ml saline, adjusted 
to pH 8,25 with 0,1N sodium hydroxide; ICdR 10 mg per ml 
saline; AzUR 20,3 nig per ml saline (double dose given 
to high dosage treated animals). All the antimetabolite 
solutions were sterilized by 0,22 micron Millipore filtration. 
Drug therapy was given at 9 am and 4 pm of Day 1, and 
twice a day at these times for six additional days. All 
injections were intraperitoneal (IP). 
At 12 noon of Day 1 each mouse received 0,4 ml of 
sheep red cell antigen by IP injection. 
The animals were sacrificed on Day 15. 
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# Mice 
at 
start 
serum 
tested 
Drug Total daily 
dosage per 
animal 
(mg/kg) 
Antibody 
coefficient 
Std. 
dev. 
of A.C. 
A.I, 
10 10 saline ^0.4 ml7 135 42 — 
5 5 BUdR 30 38 13 0.28 
5 5 IUdR 80 79 13 0.58 
5 5 ICdR 160 148 13 1.10 
5 5 AzUR 133 78 46 0.58 
5 5 AzUR 270 23 13 Oo 17 
Table lo 
Data and results of experiment 1 
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Experiment 2 
The data and results of experiment 2 are summarized 
in Table 2. 
Procedure. The drugs were made up as follows: BUdR 7»5 
mg per ml saline; IUdR 80 mg per ml DMSO (each dose was 
0.025 ml of this solution); reagent grade DMSO; azathioprine, 
made up by a water suspension having 0.1N sodium hydroxide 
added to form a solution and give a final concentration 
of 5.75 mg per ml and pH of 9«5 (made up fresh every three 
days); chloramphenicol succinate 110 mg per ml saline; 
and amethopterin 0.225 mg per ml saline with 0.1N sodium 
hydroxide added to make pH 7. Solutions were prepared 
with cleanliness but not sterilized. Drug therapy was given 
at 9 sun and 4 pm of Day 1, and twice a day at these times 
for four additional days. All injections were IP. 
At 12 noon of Day 1 each mouse received 0.2 ml of 
sh6ep red cell antigen by IP injection. This dose, which 
is half that used in experiment 1 was hoped to give a 
more sensitive titration endpoint. 
The animals were sacrificed on Day 16. 
Unfortunately the dose of chloramphenicol succinate 
used killed all five animals in that group, and amethopterin 
was lethal to four out of five animals in that group. 
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# Mice 
at 
s tart 
serum 
tested 
Drug Total daily 
dosage per 
animal 
(mg/kg) 
Antibody 
coefficient 
Std a 
dev, 
of A.C. 
A,I. 
5 5 none — 153 13 — 
5 5 BUdR 100 91 53 0o60 
5 5 IUdR 133 
in DMSO 
- 99 38 0.65 
5 5 DMSO ^.05 ml7 116 37 0.76 
5 5 Aza 50 
thio 
prine 
78 16 0.51 
5 0 Chlor,1000 
succ» 
~ 
5 1 Ameth 3 
opter 
8 — 0.06 
in 
Table 2. 
Data and results of experiment 2 
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Experiment 3 
The data and results of experiment 3 are summarized 
in Table 3* 
Procedure . The drugs were made up as follows: normal saline 
BTJdR 180 mg per ml DMSO; IUdR 360 mg per ml DMSO; reagent 
grade DMSO; CA 6 mg per ml saline; and CdR 12 mg per ml 
saline. Each dose of the halogenated pyrimidines in DMSO 
measured 0.025 ml. In the case of the simultaneous CA 
and CdR treatment the injections were given at the same 
time from separate syringes subcutaneously into opposite 
flanks. All other injections were IP. Solutions were pre¬ 
pared with cleanliness but not sterilized. Drug therapy 
was given at 12 noon of Day 1, and once a day at this time 
for six additional days. 
At 12 noon of Day 1 (directly beiore the first drug 
dose) each mouse received 0o2 ml of sheep red cell antigen 
by IP injection. 
The animals were sacrificed on Day 13. 
Unfortunately the dose of IUdR in DMSO used killed 
all ten animals in that group; one CA and one CA + CdR 
treated mouse were also found dead. 
Due to a laboratory error the results of the first 
hemagglutinin titration were obviously invalid. The sera 
remaining was froxen and another titration run. The results 
of this are on Table 3. 
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# Mice 
at 
start 
serum 
tested * 
Drug Total daily 
dosage per 
animal 
(mg/kg) 
Antibody 
coefficient 
Std. 
dev. 
of A. C. 
A.I. 
10 5 saline ^/0o 2ml/ 52 15 — 
10 6 BIJdR 130 
in DM30 
21 14 0.41 
10 0 IIJdR 400 
in DMSO 
-— ~ — 
10 8 DMSO 2^7 40 19 0.78 
10 5 CA 40 9 9 0.18 
10 8 CA+ 
CdR 
40 
80 
36 15 0,69 
Table 3, 
Data and results of experiment 3* 
*some sera lost through lab error, see text. 
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Discussion o Using the criterion of an index value of 0.60 
or lower, as chosen arbitrarily as a limiting value for 
immunosuppression by Bieber et. al. , the results indicate 
that BUdR, AzUR in the higher dosage, and CA are effective 
(2) in suppressing serum antibody formation in the mouse. ' 
■Lhe effect of CA could be prevented with simultaneous 
administration of its natural analog CdR. 
The results for azathioprine and amethopterin, well 
established immunosuppressive agents, confirm the validity 
of this experimental system. 
Confirming earlier work of others, IUdR, unlike BUdR, 
(2 5) has no notable immunosuppressive ability. ICdR, in 
its single trial, also demonstrated no activity. 
It is unfortunate that chloramphenicol succinate was 
toxic in the dosage used. Inhibition of antibody formation 
has been reported for this agent. 
The precision of the results with generally consid¬ 
erable standard deviations, suggests that in future ex¬ 
periments of this type more animals be used and that the 
(7.) 
hemagglutinin titration might be modified. 
Conclusion. These preliminary experiments give an indica¬ 
tion of the effect of various antimetabolic agents on in 
vivo serum antibody formation. For one thing, such infor¬ 
mation will allow better assessment of the immunity fact- 
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ors involved when neoplasms or virus infections are 
treated with such agents» 
This work was done during summer 19640 Since 
then these experiments have been extended 
and refined, and have recently been submitted 
( o') 
for publication. 
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Experiments on 
the Quantitation of Cellular Immunity in Mice 
Partly because cellular (delayed, tuberculin type) 
immunity has a role in polyoma virus oncogenesis, it was 
thought desirable to investigate and attempt to quantitate 
this phenomenon in order to, in possible later experiments, 
determine the effect of various antimetabolic agents on 
the development of such immunity. 
Eor convenience and economy, both in the animals 
needed and in the amounts of drugs that might be later 
used, mice were selected. Though cellular immunity mech¬ 
anisms are well known and fairly standardized in guinea 
pigs and rabbits, this technique has not been well developed 
in mice. Crowle, however, has claimed success in this 
species and his technique was attempted, as was a modified 
techniques used successfully in rabbits by Leskowitz 
and Waksman.^ ^ 
Materials and methods. 
Mice. The animals used were randon-bred specific pathogen- 
free white Swiss CD-I mice (Charles River Breeding Labora¬ 
tories, North Wilmington, Mass.), 7 to 9 weeks of age, 
with an average weight of 30 gm. Whenever the animals were 
handled, they were anesthetized with an intraperitoneal 
injection of 1.5 mg secobarbital. 
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Experiment 1 
Antigens. As described by Leskowitz and Waksman, a Freund’s 
complete adjuvant mixture was made. This adjuvant consisted 
of 8.5 ml Bayol 55 (ESSO), 1.5 ml Aracel A (Atlas Chemical) — 
both heavy hydrocarbon oils, 10 ml normal saline, and 60 
mg dead Jamaica 22, human Mycobacterium tuberculosis 
(through the kindness of Dr. B. Waksman, Department of 
Microbiology, Yale University School of Medicine). This 
was used as antigen 1. Antigen 2 was identical to antigen 1 
with 66 mg bovine gamma globulin (BGG) (National Biochem¬ 
ical) added; antigen 5 was also identical to antigen 1, 
with 0,05 ml reagent grade l-fluoro-2,4-dinitrobenzene (DNFB) 
added. Each of these antigen mixtures was homogenized by 
several forced passages through a 17 gauge needle. 
Procedure. Using the toepad (intradermal) injection route 
(2) 
found most effective in rabbits, ' the mice were injected 
with approximately 0,015 ml of antigen from a sharp 27 
gauge needle in the left hind and forefoot pads. 
During the ensuing two weeks approximately three- 
quarters of the animals were noted to have swollen, ery¬ 
thematous patches on one or both left feet at the site 
of the sensitizing injections. 
On Day 14 after the challenge, both flanks of each 
mouse were shaved with electric animal clippers. 
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The nine mice which had been sensitized with antigen 1 
(Freund’s complete adjuvant without added material) were 
then challenged with 0.05 ml normal saline intradermally 
in the left flank and 0.05 ml normal saline containing 
5 microgm tuberculin, purified protein derivative (Parke, 
Davis) intradermally in the right flank. 
The ten mice which had been sensitized with antigen 2 
(containing BGG() were challenged with 0.025 ml normal 
saline intradermally in the left flank and 0.025 ml normal 
saline containing 82 microgm BGG intradermally in the 
right flank. 
The ten mice which had been sensitized with antigen 5 
(containing DNFB) were challenged with three drops of 
acetone from a 50 guage needle on the left flank and with 
three drops of an 0.125% DNFB solution in acetone on the 
right flank. These drops were held in place until they 
dried with an aluminum template with a 4 mm aperture, 
which was pressed against the skin. 
Three days later the animals were inspected. There 
was no difference in right flank compared to left flank 
in either the tuberculin or the BGG challenged animals. 
In about 75% of the DNFB challenged animals, however, a 
defiiite Increased induration and erythema in the right 
flank as compared to the left was noted. The degree of 
this phenomenon was quite variable though. 
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As a follow-up trial the mice sensitized initially 
with antigen 2 (containing EGG) were challenged intraderm- 
ally in both right footpads with 0.015 ml normal saline 
containing 75 microgms BGG. No reaction to this was noted 
during the next three days. 
Experiment 2 
Because of the difficulty performing intradermal 
footpad injections, and the variability in the positive 
reactions in the previous experiment, Crowle's system 
was tried. 
Sensitization was carried out by placing three drops 
from a 20 gauge needle of an 0.125% DNFB in acetone solu¬ 
tion on the mouse's left flank, which had been shaved 
two days before. These drops were held in place until they 
dried with an aluminum template with a 1 cm aperture, 
which was pressed against the skin. 
One week later a booster dose, identical to the ini¬ 
tial, was given on the same area. 
Two weeks after the initial sensitizing dose, a test 
dose was given on the right flank, which had been shaved 
two days before. This consisted of three drops from a 
50 gauge of the DNFB-acetone solution, which was held in 
place until dried with the 4 mm aperture template. 
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In the following three days the development of 
erythema and induration to a considerably variable ex¬ 
tent was noted at the right flank challenge site of 
about 80% of the animals; at three days necrosis was 
apparent in about 50%. Ten mice were used in this ex¬ 
periment . 
The procedure was essentially that of Crowle, who 
used chlorodinitrobenzene and a smaller challenge dose 
of one drop. 
Discussion. While it was obvious that both experimental 
trials using DKFB worked moderately well, the considerable 
variability and innate anatomical characteristics of the 
challenge reaction made quantitation hardly possible. 
This experimental area was not investigated therefore, 
and no attempt to assess drug effects on this system have 
been made. 
Several other investigators have attempted to use 
mice in tests involving delayed hypersensitivity with 
O') 
negligible results.v ' 
This area is obviously an important one; such immunity 
O') is known to vary in human neoplasia.vJ 
This work was done during the 
summer of 1964. 
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Experiments on 
the Effects of Antimetabolic Drugs on Polyoma Virus 
Oncogenesis in Newborn Hamsters 
As detailed in the review section of this thesis, 
certain anti-metabolic agents, such as the pyrimidine 
analogs, inhibit the in vitro and in vivo replication 
of DNA viruses, as well as having direct anti-neoplastic 
properties. ^ jjuebner ej; al. has shown that 
adenovirus 12 oncogenesis in newborn hamsters could be 
suppressed with one of these agents, 5-iodo-2'-deoxy- 
uridine (IUdR).^^ 
This series of experiments was undertaken to de¬ 
termine whether such compounds could suppress polyoma 
virus oncogenesis in newborn hamsters. 
Materials and methods. 
Hamsters. The animals used were random-bred golden 
Syrian hamsters, usually less than one day old, always 
less than two days old. Pregnant females, about to de¬ 
liver in the next several days, were purchased from 
Putney Cavey, Stratford, Conn. These animals were placed 
in a virus-free room to await delivery. 
Litters averaged six to ten newborns. 
Directly before virus injection the mother hamster 
and newborns were moved to the experiment room. 
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At about 21 days of age surviving young animals 
were removed from their mothers and caged separately. 
The animals were observed twice daily; when presence 
of tumor was not obvious, appropriate histologic sections 
were made for microscopic examination. 
A number of animals were killed by their mothers 
shortly after human handling and injection; these were 
randomly distributed. Deaths during the first ten days 
were considered nonspecific and have not been included 
in the following tabulations. 
Viruso The previously described "Toronto" strain of poly¬ 
oma virus was used. This was produced and supplied through 
the courtesy of Dr. E.L. Black, Department of Epidemiology 
and Public Health, Yal6 University. 
Virus was harvested from infected mouse embryo tis¬ 
sue cultures. After sonification of the cells the virus 
was concentrated by differential centrifugation to a 
O 
titer of approximately 10 tissue culture infective doses, 
50% effective. The hemagglutination titer was 1:1024 to 
1:2048. When less concentrated doses were given, dilution 
was made with fresh tissue culture medium. A dose of 
0.1 ml of the particular concentration was given. 
Drugs. The following drugs were used: normal (0.9%) 
saline; 5-iodo-21-deoxyuridine (IUdR), lot #5272, pur- 
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chased from Nutritional Biochemicals Corp.; 5-iodo-2l- 
deoxycytidine (ICdR), prepared by P.K. Chang, Depart¬ 
ment of Pharmacology, Yale University School of Medicine; 
and 6-azauridine (AzUR), obtained from the Cancer Chemo¬ 
therapy National Service Center as NSC 32074-, lot #12- 
34-004, The drugs were dissolved in saline so that each 
dose given would be in 0,1 ml of solution. The IUdR 
solution was stabilized by the addition of 0.1 N sodium 
hydroxide to make pH 8,3* All solutions were sterilized 
by 0.22 micron Millipore filtration. 
The initial drug dose was given directly after virus 
injection in all cases. 
All injections of virus were intraperitoneal (IP). 
Drugs were administered subcutaneously (SC) or IP as in¬ 
dicated in the following tables. In all cases virus and 
drug were administered separately. 
Table 1 lists the deaths of animals given various 
virus concentrations without drug or with saline treat¬ 
ment , 
Table 2 lists data on animals treated with IUdR. 
Table 3 lists data on animals treated with ICdR or 
AzUR. 
Table 4 compares animals injected with virus at 
various dilutions with and without treatment. 
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Virus Survival time in days, 
cone. + or - for tumors (x 
H of animals) 
Average Standard 
survival deviation 
time 
10° 12+x8,15+,17+x2,18+x8, 19*5 
19+x4,21+x3,22+x2,24+, 
28+x2,37+,54+ 
1CT1 15+,28+x2,29+x3,30+x3, 33.3 
31+x2,32+,35+,38+x2, 
39+,42+x2,43+,46+ 
-2 13+x2,14+,15+x3,30+x3, 38.0 
31-kx2,32 + , 35+»38+x2, 
39+»4-2+x2 ,43+,46+</T61-7 
8o2 
7.2 
39.2 
10"5 27+,29+,35+,38+,41+x2, 47.3 24.0 
42+,59+,104+ /T36+*, 
150-,400-*x4/ 
Table 1. 
Deaths of newborn hamsters given various virus concentra¬ 
tions and no drug treatment. 
*sacrificed **deaths in brackets have not been 
included in averages 
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Virus 
cone. 
Drug, 
route 
# of 
doses 
Dose 
freq. 
10° IUdR, 
• 5mg, 
IP 
1 -— 
10° IUdR, 
• 5mg, 
IP 
5 1/d ay 
10° IUdR, 
o5mg, 
SC 
10 alter 
nate 
days 
10_1 IUdR, 
o5mg, 
SC 
10 alter 
nate 
days 
10~2 IUdR, 
• 5mg9 
SC 
10 alter 
nate 
days 
10-5 IUdR, 
»5mg, 
SC 
10 alter 
nate 
days 
Survival time Aver, 
in days, + or surv. 
- for tumors time 
(x# of animals) 
Std. 
dev. 
13+,18+,21+ 17.3 3.8 
22+,26+,27+x2, 34,6 
71 + 
20.0 
25+,30+,37+, 36.6 
41+ ,30+ 
15.6 
35 +,67+,87+, 63»0 
/T3-,15-,17-x2, 
25-,29-,32-*43-, 
58-,136+17 
26.2 
34+,89+^34-,42-,61.5 
^4-,45-,53-,73-, 
153-,136-17 
— — — 
68+/T5-,30-, 68 
31-x2,32-,34-, 
36-,46-,63-,88-, 
92-,134-,164-, 
166-,170-,170-*, 
400-*7 
2. Table 
Deaths of newborn hamsters treated with IUdR, 
*sacrificed **deaths in barckets have not 
been included in averages 
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Virus 
c one. 
Drug, 
route 
# of 
doses 
Dose 
freq. 
Survival time 
in days, + or 
- for tumors 
(x# of animals 
Aver. 
surv. 
time 
) 
Std 
dev 
10° ICdR, 
«5mg, 
IP 
1 —— 12+,13+,21+x3 17 o 6 4.7 
10° ICdR, 
Img, 
IP 
1 —— 15+,16+x2,24+ 
x2,25+,26+ 
20.9 4.9 
10° ICdR, 
»5mg, 
SC 
5 1/d ay 23+,25+,28+, 
31+ 
28.8 4.2 
10° ICdR, 
Img, 
SC 
10 alter 
nate 
days 
ZT9-,20-7 —— ■- 
1CT1 ICdR 
Img, 
SC 
10 alter 
nate 
days 
ZT7-,23z.7 —;—- — ~ —• 
10° AzUR, 
o , 
IP 
1 14+,15+x2,21+, 
22+,24+ 
18.5 4.3 
Table 3> 
Deaths of newborn hamsters treated with ICdR 
and AzUR. 
**deaths in brackets have not been 
included in averages 
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Virus cone. 10° IQ-1 
OJ
 
i
 o
 
1
—1
 10-5 
NO Tumors/Total 
TREAT¬ 
MENT 
55/53 20/20 11/12 10/15 
% Tumors 100 100 92 67 
Aver. surv. 
time with 
tumor (days) 
19.5 33.3 38.0 47 o 3 
IUdR Tumors/Total 
xlO 
5/5 V13 2/10 1/18 
ALTER% Tumors 
NATE 
DAYS 
100 31 20 6 
Aver. surv. 
time with 
tumor (days) 
36.6 63.0 61.5 68 
Table 4. 
Comparison of newborn hamsters injected with virus at 
various concentrations with and without IUdR treatment. 
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Discussion. Most of the animals dying within a month 
after virus injection had gross kidney and/or heart 
tumors. Longer surviving animals were considered to 
have died from tumor if death was related to intraperi- 
toneal hemorrhage from vascular dilatations, generally 
of the liver, or later still to large subcutaneous fibrous 
tumors. 
The results showing longer life then more dilute 
virus was used confirms the work of Axelrad e_b al. ^^ 
From Table 4 which compares animals given various virus 
concentrations with IUdR treatment and without treatment, 
it is apparent that treated animals which received un¬ 
diluted virus developed tumors without exception but had a 
much longer survival time than similar untreated animals. 
Also of note is that the animals which received diluted 
virus, when treated with IUdR developed considerably fewer 
tumors than the untreated animals. This indicates IUdR 
is effective in suppressing polyoma virus oncogenesis 
in newborn hamsters. Whether IUdR acts against the virus, 
which would seem most likely, or against the tumor cannot 
be determined from this experiment. 
Unfortunately the data from the ICdR and AzUR treated 
animals is not sufficient to make such comparisons. 
Many more animals were treated with AzUR and ICdR 
than are shown in these results. It was concluded that 
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AzUR, which has been reported to have selective action 
against mouse embryos, is toxic for newborn hamsters, 
(12) 
which are born in an immature state. ' 
Due to a laboratory error the ICdR solutions were 
not kept in dark storage. In retrospect, the slight 
brownish discoloration which had been noted in these 
solutions was probably free iodine, indicating ICdR 
breakdown. Quite likely iodocytosine, a known toxic 
(2 5) breakdown product, was also formed. 
Several trials were made with cytosine arabinoside, 
without any surviving animals. 
The deaths of young animals without tumor cannot be 
accounted for. 
This work was done during the 
summer and fall of 1964. Part 
of this work has been included 
in a recent publication.'^ 
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Experiments on 
Polyoma Virus Oncogenesis in Adolescent Hamsters i'reated 
with Immunosuppressive Agents 
Since hamsters more than three to four weeks old 
are resistant to polyoma virus oncogenesis, it was decided 
to investigate whether this resistance could be altered 
(1 5) 
by various immunosuppressive agents. 
llhe agents selected were: reserpine, which has been 
reported to cause thymic involution and skin homograft 
tolerance in ratswy; melphalan, which has been reported 
to suppress antibody and homograft response^; radiation, 
a well recognized agent for immune suppression which 
renders ordinarily resistant adult mice susceptible to 
(7) polyoma virus oncogenesisw; and azathioprine, a well 
recognized effective agent in suppressing serum as well 
as cellular immunity.^'* 
Materials and methods. 
Hamsters. The animals used were random-bred golden Syrian 
hamsters, 8 to 10 weeks old, weighing approximately 40 to 
50 gm each. These animals were purchased from Putney 
Cavey, Stratford, Conn, (experiment 1) or from Lakeview 
Parms, Lakeview, N.J. (experiment 2). Adolescent animals 
were selected so that less drug would be needed and longer 
follow-up would be possible. These animals were placed 
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in a virus-free room initially and transferred to the 
experiment room directly prior to virus injection. 
Drugs. The following drug were used: normal (0.9%) 
saline; reserpine parenteral solution (Serpasil, CIBA); 
melphalan (phenylalanine mustard, sarcolysin, Alkeran, 
Burroughs Wellcome); and azathioprine (Imuran, BW 57” 
322), lot #4-5374-* obtained through the kindness of Dr. 
G.B. Elion of Burroughs Wellcome and Co. 
Virus. The previously described "Toronto” strain of 
polyoma virus was used. This was produced and supplied 
through the courtesy of Dr. F0L. Black, Department of 
Epidemiology and Public Health, Yale University. 
Experiment 1 
I. Three days prior to virus injection each of ten 
animals received a dose of reserpine at Img per kg. 
Commercial Serpasil solution was diluted with sterile 
water (saline caused precipitation of the reserpine) to 
a concentration of 0.2mg per ml for this purpose. The 
following day two animals were found dead; nevertheless 
the dose of reserpine was repeated. The next day (one day 
prior to virus injection) the eight remaining appeared 
so sick with lethargy and diarrhea that no dose was 
given. One the day of virus injection and for each of 
21 days following the animals received reserpine at 
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Go 5 mg per kg per day. Two more animals, however, died 
early in the experiment. This was thought due to drug 
toxicity. Throughout the course of reserpine therapy 
the animals in this group appeared chronically sick 
and failed to gain weight. 
II. The day prior to virus injection each of ten 
animals received an injection of melphalan at 10 mg per 
kg. For this injection melphalan pills were crushed and 
suspended in saline. No other doses of this drug were 
given. 
III. The day prior to virus injection twelve animals 
received 350 rads of x-irradiation (an estimated IJ^q), 
through the kindness of Dr, C. von Essen, Department 
of Radiology, Yale University School of Medicine. 
IV. On the day of virus injection (directly prior 
to virus) each of ten animals received an injection of 
azathioprine at 75 mg per kg. This azathioprine solu¬ 
tion was made up by suspending the drug in water, adding 
O.XN sodium hydroxide to form a solution and give a pH 
of 9.5. This solution was made up fresh every three 
days. Each animal daily received the same dose for 13 
more days. 
V. Ten animals for control received no treatment 
whet ever 
T *1"c 3m 
aJminB sjrfct 
. tflyisv; aleg otf bdllsl? Jboa 
- 1 Lola q •* e 5 priT . II 
nol^DSGfii ns JdsvIsooi alefflliXA 
f ' ' i: 4 1C'lT . 'A 
,31:1 ,>S ai &9bn9qSJJB 
. r via 
6 3ilT .III 
. 
^goIoibsS lo 
■'do aO .VI 
snlaqoirflssB 
1,0 
r ;T -c4.P lO 
, 1 e b 
r-b sac m 
. 
-68- 
All injections of virus and drugs were intraperitoneal, 
with the exception of the azathioprine injections which 
were subcutaneous. 
Each animal received 0,5 ml of hemagglutination titer 
1024 virus on Day 1. 
The animals were observed daily. All dead animals 
were autopsied; when presence of tumor was not obvious, 
appropriate histological sections were made for micro¬ 
scopic examination. Due to keeping the hamsters in mouse 
cages which were not satisfactorily secure for these 
larger animals, a number escaped and could not be accounted 
for. 
The results are shown in Table 1. 
Discussion. Of note is that 5 out of 7 azathioprine treated 
animals accounted for developed and died of tumor, 5 
reserpine treated animals also died of tumor. 
The considerable number of young animals dying 
without evidence of tumor in the melphalan treated, x- 
raved and control groups cannot be explained. 
The results indicate that hamsters at an age ordin¬ 
arily resistant to polyoma virus oncogenesis, can be 
rendered susceptible with reserpine and azathioprine. 
This work was done during the 
summer of 1964, 
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# Animals 
accounted 
Treatment Survival time 
in days, + or 
- for tumor 
(x# animals) 
Aver, 
surv. 
time * 
% with 
tumor 
6 Reserpine 6-,9-,19+,37+, 
77+,400±* 
44.3 50% 
8 Melphalan 9-,17-,22-,28- 
38-,43-,75-, 
109- 
i — — — 
11 X-ray 12-,19-,26-,83- 
x2,85-i153-1 
260-,320-,400* 
x2 
* 
7 Azathio- 
prine 
24+x2,25+,67+, 
85+i320-x2 
45^3 71% 
5 Control 25-,29-,31-, 
400i*x2 
—.— — 
*deaths from tumor **sacrificed 
Table 10 
Immunosuppressive Agent Treated Adolescent Hamster Polyoma 
Virus Tumor Deaths 
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Experiment 2 
Since the results of experiment 1 in the reserpine 
and azathioprine treated animals were of such interest, 
it was decided to repeat this part of the experiment 
using larger numbers of animals. 
I. Three days prior to virus injection each of ten 
animals received reserpine in water solution at 0.25 mg 
per kg. This was continued on a daily basis up to the 
virus injection and for each of 21 days following this. 
During this drug therapy 22 of these animals died; this 
was difficult to control since these deaths were spread 
out over the therapy period, and the animals would appear 
well at the time of an injection only to be found dead 
later the same day or the next day. 
II. Starting on the day of virus injection 25 animals 
received azathioprine, prepared as in experiment 1, at 
75 nag per kg. Each animal received this dose daily for 
11 more days. 
III. Starting on the day of virus injection 25 
animals received normal saline at 0.5 ml per animal. 
Each animal received this dose daily for 11 more days. 
This group was used as experimental control. 
All injections of virus and drugs were intraperitoneal, 
including the azathioprine. 
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Each animal received 1.0 ml of hemagglutination titer 
512 virus on Day 1. 
The animals were observed daily. All dead animals 
were autopsied. 
Results. At the end of the drug treatment period 22 of 
the reserpine treated, 1 of the azathioprine treated and 
1 of the saline treated control animals had died. 
As of 160 days after virus injection 3/25 of the 
reserpine treated, 23/25 of the azathioprine treated and 
20/25 of the saline treated control animals were alive 
and in apparent good health without any evidence of tumor. 
The experiment was terminated at this point and the 
animals sacrificed. 
Of the deaths that occurred before 160 days, except 
for the 22 deaths that occurred during the drug therapy 
period in the reserpine treated animals which were 
thought due to the toxicity of that drug, all were 
non-specific and showed no signs of tumor on autopsy. 
It was speculated that this apparent failure to repeat 
the results in experiment 1 may have been due to a poor 
lot of virus. 
If the results of experiment 1 are accepted, it 
is apparent that azathioprine depresses the ordinarily 
good resistance of adolescent hamster© to polyoma virus 
tumor induction. Of special interest is that reserpine 
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which is not ordinarily thought of as an anti-immune 
drug, also appears to do this. Of note also is that 
reserpine appears to be quite toxic for hamsters, killing 
the animals with one-quarter the dose tolerated well 
by rats. 
The work of experiment 2 was 
done during the fall of 1965* 
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Experiment on 
Polyoma Tumor Cell Transplantation in Adolescent Hamsters 
Treated with Azathioprine 
Hamsters more than three to four weeks old are 
(1 3) 
resistant to polyoma virus oncogenesis. Ordinarily 
susceptible newborn hamsters can be protected by passive 
transfer of antipolyoma virus antibody prior to viral 
inoculation. ' This antibody, however, appears to 
have no effect when given to an animal with an already 
established tumor. In order to further determine whether 
serum antibody or cellular (delayed hypersensitivity, 
tuberculin type) is operative in the animal's resistance 
to the tumor itself, an experiment was performed. 
Hamsters received inocula of polyoma virus-induced 
tumor cells. Half the animals received a course of 
azathioprine, a drug thought to be more suppressive of 
cellular type hypersensitivity and to have less effect 
(2 5) 
on antibody type immunity. 'yJ 
Mat erials and me thods. 
Hamsters. The animals used were random-bred golden Syrian 
hamsters, 8 to 10 weeks old, weighing approximately 40 
to 30 gm each. These adolescent hamsters were purchased 
from Lakeview Farms, Lakeview, N.J. Animals this age and 
size were selected so that less drug would be needed and 
longer follow-up -would be possible. These animals were 
V. _ .^ • :£■*.•: • ov Xoi 
. o 
0 , -'J CL J c. . ? d - Lh r' LilQC ■/$■. • 9 ‘ Cfl l1. 903US 
’L'Oli *flB EV! iV OOvIoCtI j £L£? lO 1913X1-6*1^ 
. 
. i fiu/3 £>®jriBi I : -rdee 
rji b^vB.Csb) 16 lull so io ^bodxd'isfi wt% s a 
1 
. t J r? X ICfflU3 'Hid oct 
■■ 
. 
< ••-.!: rqoixid'uss 
: gvj 1£luCl9 0 
.. ^bod.fctfriB no 
• j__ . .... 119^61:4 
• •• -■ - 
f ' I ' ( 3il 
. 
. . r f >£V93£sI moil 
. gxf-v.oII ol i9gnoI 
-74- 
placed in a virus-free room when received in order to 
prevent accidental infection with polyoma virus and 
the development of immunity and resistance from this. 
Directly prior to tumor cell inoculation the animals 
were transferred to the experiment room. 
Drugs. Azathioprine (Imuran, BW 57-322), lot #45374, ob¬ 
tained through the kindness of Dr. G.B. Elion of Bur¬ 
roughs Wellcome and Co. was used. This was made up by 
suspending the drug in water and adding sodium hydroxide 
0.1 N to form a solution of pH 9<>5« This was made up 
fresh every three days. This drug was administered by 
intraperitoneal injection. The animals received the 
initial dose of 75 mg per kg two hours after tumor cell 
inoculation. Drug therapy was continued at this dosage 
level for 11 more daily doses. 
Tumor cells„ Two polyoma virus-induced subcutaneous tumors 
(4 x 2 cm over the right shoulder, 3 x 4 cm on the abdom¬ 
inal wall outside the peritoneum) from a randomly selected 
adult hamster were used. An attempt was made to remove 
these tumors sterilly and continue the processing under 
sterile conditions. The tumors appeared well encapsulated; 
their centers may have been slightly necrotic. 
The tumors were minced. This product was agitated 
for ten minutes in a 30 ml aliquot of 0.25% trypsin in 
buffered phosphate solution. This process was repeated 
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six times. After each agitation the supernatant tumor cell 
suspension was poured off into a container set in ice. The 
collected supernatant suspensions were filtered through 
several layers of sterile cotton gauze to remove larger 
particles of tumor which had not broken down. This filtrate 
was gently centrifuged at very low speed in a refrigerated 
centrifuge for ten minutes. The concentrated tumor cells 
were then adjusted, after hemocytometer counts, in Eagle’s 
Minimal Media with Hank’s Salt Base to concentrations of 
10^, 10^, 105 sind 104 cells per ml. 
The tumor cells, in one ml doses, were injected sub¬ 
cutaneously into the backs of the animals, 
7 
Of thirty control animals ten received 10 cells, 
6 5 
ten 10 cells, and ten 10^ cells. Of thirty azathioprine 
6 5 
treated animals ten received 10 cells, ten 10^ cells, 
4 
and ten 10 cells. This schedule was adopted since it 
was thought that the treated animals might be more sus¬ 
ceptible, and this skewing would give more precise data 
with larger animal groups. 
The results are summarized in Table 1. 
The tumors were all subcutaneous growths, invariably 
on the back of the animals where the cells had been in¬ 
jected. Tumor size range from 3 cm diameter in animals 
which died early to frequent growths 10 cm diameter or 
over, dwarfing the animal under the tumor mass, in ham- 
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# Animals 
accounted 
Tumor 
cell 
dose 
Treat¬ 
ment 
Survival time 
in days, + or 
- for tumor 
(x # animals) 
Avert 
surv. 
time 
Std. 
dev. 
10 10? Con¬ 
trol 
16+,23+,26+, 
28+,29+x2,36+, 
39+,46+,55+ 
32o7 11.5 
10 106 Aza¬ 
thio¬ 
prine 
8-,26+,27+x3, 
59+i42+x2, 
55**2 
32.8 7.7 
10 106 C 9- ,20+,32+, 
34+x2, 35+, 
38+x2,43+,55+ 
36.6 9.3 
9 105 A 18+,22-,39+x2, 
42+,45+,49+x2, 
55+ 
42.0 12.0 
10 105 C 18-,35+,59+x2, 
49+,55+x2, 
55+x2 
48.1 8,2 
10 104 A 5-,42+,48+x2, 
49+,53+,55+x4 
51.0 4.6 
Table 1. 
* animals with 
tumor 
* ^sacrificed 
Survival Time of Adolescent Hamsters with and without 
Azathioprine Treatment 
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sters which survived longer. Autopsies revealed no in¬ 
ternal tumor. 
Several hamsters were sacrificed to obtain tumor 
for other experiments, in all cases these animals were 
moribund and have been considered as natural deaths in 
the tabulation. 
Discussion. Inspection of Table 1 reveals that animals 
receiving azathioprine had shorter survival times than 
control animals receiving identical tumor cell inocula. 
Indeed, the azathioprine treated animals have survival 
times comparable to control animals receiving tumor 
cell inocula ten times larger. 
Though these animals were random-bred and not pure 
strain hamsters, hamsters generally tolerate transplants 
from other random-bred peers well. This and the fact 
that the control animals accepted the tumor transplant 
so well, probably indicates lack of any homograft resistance 
phenomenon to hamster tissue itself which might have 
been suppressed by azathioprine. It seems reasonable to 
conclude this experiment further indicates resistance 
to antigen-specific tumor tissue is based on a cellular 
type immunity, which azathioprine suppressed in the 
treated animals, accounting for the results. 
This work was done during the 
fall of 1965. 
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Experiments on 
Hamster Polyoma Virus-Induced Tumor Cell Response to 
3-Iododeoxyuridine in Tissue Culture 
In order to determine whether polyoma virus-induced 
tumor in hamsters had any unusual susceptibility or 
resistance to 5-iododeoxyuridine (IUdR) it wqs decided 
to test such tumor cells in tissue culture with the anti¬ 
metabolite in the medium. 
Materials and methods. 
Tumor cells. A polyoma virus-induced subcutaneous tumor 
(3 cm diameter over the left flank) from a randomly 
selected adult hamster was used. An attempt was made to 
remove and process this tumor under sterile conditions. 
The tumor appeared well encapsulated; its center may have 
been slightly necrotic. 
The tumor was minced. This product was agitated for 
ten minutes in a 30 ml aliquot of 0.25% trypsin in buffered 
phosphate solution. This process was repeated four times. 
After each agitation the supernatant tumor cell suspension 
was poured off into a container set in ice. The collected 
supernatants were filtered through several layers of sterile 
cotton gauze to remove larger particles of tumor which 
had not broken down. This filtrate was gently centrifuged 
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at very low speed in a refrigerated centrifuge for ten 
minutes. The concentrated tumor cells were then adjusted, 
after hemocytometer count, in Hank's Salt Base with 0.5% 
lactalbumin hydrolysate and 2% calf serum (HIS) to a 
concentration of 300,000 cells per ml. 
4 ml of this suspension was plated in several twenty 
ml plastic culture bottles, and about 50 ml in several 
one liter Rous bottles. These bottles were incubated at 
57°C. 
Every three to four days, when the color of the medium 
changed from its fresh pink to yellow, indicating cellular 
matabolism and acid production, the media were changed. 
The cells attached well to the bottles. Bacterially con¬ 
taminated cultures were discarded as they occurred. 
A pericardial tumor and an enlarged vascular liver 
culture from a polyoma infected hamster, started at the 
same time as the subcutaneous tumor, did not grow well 
and were never used. 
Thirteen days after initial culture, the subcutaneous 
tumor cells were removed from one of the Rous bottles. 
This was done by pouring out the culture medium (HLS) 
and incubating the cells for fifteen minutes at 37°C 
with fifty ml 0.25% trypsin in buffered phosphate solu¬ 
tion. With moderate agitation the cells were freed from 
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the glass surface. This suspension was gently centrifuged 
at very low speed in a refrigerated centriguge for ten 
minutes. The concentrated tumor cells were then adjusted, 
after hemocytometer count, in HLS medium to 360,000 cells 
per ml. -‘•his suspension was plated in a number of regular 
and ultra-short Leighton tubes (small tissue culture 
chambers) with 1% and 1 ml respectively. 
Drug. 3-iodo-2'-deoxyuridine (IUdR), lot #5272, purchased 
from Nutritional Biochemicals Corp., was used. An 0,1% 
solution of IUdR in normal (0.9%) saline was made up and 
sterilized by 0.22 micron Millipore filtration. This 
solution was added to HLS medium, to make up final con¬ 
centrations of 100, 31*6, 10 and 3*16 microgm IUdR per 
ml medium 
Rorty-eight hours after the Leighton tubes were started 
good cell attachment with fairly uniform cell density 
had taken place. Th.6 initial plating media was poured 
off and the new media with various concentrations of IUdR 
was added. 
Borty-eight hours after this, the lUdR-HLS media was 
poured off. Methyl alcohol was placed in the tubes for 
about five minutes to fix the cells. This was poured off 
and a solution of one drop concentrated Giemsa stain per 
ml distilled water was poured in for thirty minutes to 
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stain the cells. This stain was poured off. The tubes 
were rinsed with distilled water and filled with heavy 
clear mineral oil and sealed. 
The number of cells per ten high power microscope 
fields was counted for each tube. The results: 
Tube 
Control 
IUdR, 3ol6 
IUdR, 10 
IUdR, 31.6 
IUdR, 100 
# of tubes 
8 
6 
6 
6 
6 
average # cells/HPF 
141 
12? 
110 
119 
148. 
In retrospect it was thought thses results were not 
reflective of IUdR effect since the cell density was so 
high in every tube* 
Dr. Jack Cramer, Department of Pharmacology, Yale 
University School of Medicine, was consulted. He suggested 
plating the cells at a lower concentration, since the 
effect of IUdR could best be determined by following 
cell replication. 
Accordingly a new trial was done. 
The previously described subcutaneous tumor cell 
line was again used. These cells had been trypsinized off 
the Rous bottles once and split into two culture bottles 
each during the three weeks since initial culture. 
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In order to determine the effect of IUdR on normal 
hamster tissue, cultures of kidney and testicle were 
prepared from a normal male hamster. The former organ 
was selected since it usually forms good epitheloid sheets, 
the latter because of its considerable fibrous cells 
similar to subcutaneous tumor cells. 
Unfortunately the initial kidney cell cultures were 
all grossly contaminated and were discarded. 
As in the first trial the tumor cells were suspended, 
this time, in concentrations of 100,000 and 20,000 cells 
per ml media made from Eagle's Essertial media, 5% fetal 
calf serum, 3% of a 71^% sodium bicarbonate in water solu¬ 
tion and 1% of standard tissue culture antibiotic mixture. 
Testicular cells were made up at 100,000 cells per ml in 
this same media. A number of Leighton tubes were plated 
with V/z ml each of one of these three suspensions. 
Twenty-four hours later this initial media was removed 
from the Leighton tubes, and HLS media with various con¬ 
centrations of IUdl^ as used in the first trial, was added. 
The cells in the Leighton tubes containing the 
subcutaneous tumor at the 100,000 cells per ml plating 
dilution were counted each for reticuled grid areas in 
five high power fields prior to the addition of the IUdR 
medium and at each twenty-four hour mark after this addi- 
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tion. These results are summarized in Table 1, 
The tubes plated with tumor cells at 20,000 cells 
per ml showed much debris and less than 3 cells per 
such field when counted in the same manner,, There were 
no useful results from tnis trial. 
The tubes plated with testicular cells were all 
grossly contaminated and were discarded. 
Discussion. The data of Table 1 shows, especially at Day 
3, IUdR affects this hamster polyoma-induced subcutaneous 
cell line in a manner similar to that reported by Buthala 
in He La, HEp-2, and rabbit and rat normal kidney cells 
(summarized on p. 32 of this thesis).^1'' This would in¬ 
dicate that hamster polyoma-induced tumor in general 
probably has no unique resistance or susceptibility to 
IUdR. 
Of some relevance is the report that IUdR at a 
concentration of 10 microgm per ml media inhibits the 
formation of infectious polyoma virus in mouse embryo 
cell cultures. 
This work was done during the 
fall of 1965. 
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Day 0 
Tube # Control 
1 79 
2 153 
5 60 
4 72 
5 73 
6 67 
7 87 
Total 
average 82 
Day 1 
Tube ff Control 10 IUdR 22 100 300 
1 94 85 25 75 2 
2 41 60 57 57 5 
5 47 55 38 75 5 
4 59 56 50 80 4 
5 85 53 40 68 2 
6 61 
7 63 
Total 
average 64 62 42 71 4 
Da.y 2 
Tube # Control 10 IUdR 30 100 300 
1 89 56 8 43 0 
2 134 90 32 33 2 
3 74 96 64 47 0 
4 149 66 41 33 1 
5 31 60 27 54 1 
6 73 
7 31 
Total 
average 67 74 41 42 1 
Table 1. 
(continued on p0 85) 
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Da.y 3 
Tube # Control 10 IUdR 30 100 300 
1 113 31 2 7 0 
2 49 109 10 10 0 
3 124 97 70 5 0 
4 41 65 32 17 0 
5 68 38 18 18 0 
6 80 
7 26 
Total 
average 59 68 16 11 0 
Table 1. 
Average number of hamster polyoma-induced tumor cells 
per high power reticuled grid field at various times 
with IUdR concentrations of 10, 30, 100 and 300 microgm 
per ml media,, 
/Js a follow-up demonstration to show this tumor 
cell line was still malignant in vivo, cells were 
trypsinized off several Rous bottles and injected ^ 
into normal hamsters. Three animals received 2 x 10to 
cells; two, 2 x Kr cells. All developed about 2 
cm tumors in the next month./ 
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Discussion of Experimental Results 
These experiments have shown that IUdR is effective 
in prolonging the life or completely inhibiting the 
development of polyoma virus tumors in newborn hamsters. 
Since IUdR is known to have only limited success as an 
antineoplastic agent, and was experimentally shown here 
to have no special toxicity for polyoma tumor tissue in 
culture, it is likely that IUdR5s protection of newborn 
hamsters from polyoma viral oncogenesis is due to its 
antiviral effects. From the limited suppression of serum 
immunity in mice by IUdR, it is likely that the develop¬ 
ment of this immunity in newborn hamsters is not especially 
elfected. 
Of considerable interest is the viral induction 
of tumor shown to take place in relatively mature hamsters 
under treatment with reserpine and azathioprine. This 
indicates virus is effective in causing malignant trans¬ 
formation of cells in these animals. Therefore their 
natural resistance to tumor development must lie in con¬ 
trolling virus by serum immune factors at an early stage 
(and the drugs have hindered the development of such 
protection), or the drugs have hindered the development 
of immunity against the beginning tumor itself, which 
these animals are ordinarily capable of rejecting. That 
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this latter experiment is most likely is shown by the 
experiment in which azathioprine treated animals given 
polyoma tumor cell transplants had shorter survivals than 
untreated controls, A logical future experiment would 
be to repeat this, giving sufficiently small quantities 
of tumor cells so that treated animals would develop 
tumors but control animals would not. 
Polyoma viral transformation is well known to leave 
the cells with a characteristic tumor antigen. It therefore 
seems when the animal is incapable of recognizing and 
handling these malignant cells, most likely done ordin¬ 
arily by the process of cellular (delayed) immunity, 
tumor growth and death occurs. 
It is fascinating to speculate that resistance of 
this type to malignancy may be based on cellular, delayed 
type hypersensitivity. Perhaps this accounts for the 
weak tuberculin reactions of humans with cancer, the 
relative peak of malignancy in childhood as might occur 
in those individuals not developing this type of immunity 
well, and the increased rate of tumors as second primaries 
in those with one malignancy already present. Indeed, 
malignant transformation may not be the rarity it would 
seem; such transformation may be far more frequent than 
suspected with most being successfully eliminated by 
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the cellular immune mechanism. An interesting clinical 
study that here suggests itself is whether people on 
immunosuppressive therapy or even on extended reserpine 
treatment have an increased rate of malignancy. 
!J-'hese experiments were started with certain questions 
now there are other questions. 
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